This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Richard D. Heimbach, MD, PhD
US Air Force School of Aerospace Medicine Brooks AFB, Tex

JAMA. 1981;246(22):2574.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

I read Dr Neubauer's letter with a great deal of anticipation, hoping he would bring to light studies that did not suffer from the deficit inherent in those with which I am acquainted, that is, the lack of proof that patients who have suffered strokes and been treated with HBO do better clinically than those not so treated. Such a difference in outcome is still the bottom line in ascertaining the efficacy of any treatment modality. Unfortunately, the references given by Dr Neubauer, all of which I am aware of, suffer from this deficit. In stroke patients who exhibit a wide range of clinical recovery for long periods after their initial episode, only controlled studies, preferably double blinded, will provide the degree of proof necessary for HBO to be acceptable as effective treatment.

It is interesting and somewhat ironic that I, who devote full time to the study . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?